These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2709678)

  • 61. Long-term control of plasma calcitriol concentration in dogs and humans. Dominant role of plasma calcium concentration in experimental hyperparathyroidism.
    Hulter HN; Halloran BP; Toto RD; Peterson JC
    J Clin Invest; 1985 Aug; 76(2):695-702. PubMed ID: 3928683
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration.
    Takamoto S; Onishi T; Morimoto S; Imanaka S; Tsuchiya H; Seino Y; Yokokawa T; Iida N; Kumahara Y
    Nephron; 1985; 40(3):286-91. PubMed ID: 3839293
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease.
    Koenig KG; Lindberg JS; Zerwekh JE; Padalino PK; Cushner HM; Copley JB
    Kidney Int; 1992 Jan; 41(1):161-5. PubMed ID: 1593853
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol.
    Lopez-Hilker S; Dusso AS; Rapp NS; Martin KJ; Slatopolsky E
    Am J Physiol; 1990 Sep; 259(3 Pt 2):F432-7. PubMed ID: 2396669
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interrelationships between circulating vitamin D metabolites in normocalciuric and hypercalciuric renal stone formers.
    Gascon-Barré M; D'Amour P; Dufresne L; Perreault JP
    Ann Nutr Metab; 1985; 29(5):289-96. PubMed ID: 3876804
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 1,25-(OH)2-16ene-23yne-D3 reduces secondary hyperparathyroidism in uremic rats with little calcemic effect.
    Lippuner K; Perrelet R; Casez JP; Popp A; Uskokovic MR; Jaeger P
    Horm Res; 2004; 61(1):7-16. PubMed ID: 14646396
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin in chronic renal failure.
    Franck H; Keck E; Issa S; Krüskemper HL; von Lilienfeld-Toal H
    Exp Clin Endocrinol; 1988 May; 91(2):202-6. PubMed ID: 3409970
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased clearance rate of prednisone in the isolated perfused liver of uremic rats.
    Egfjord W; Langhoff E; Daugaard H; Olgaard K
    Nephron; 1987; 45(1):53-8. PubMed ID: 3808150
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of age and estrogen on renal vitamin D metabolism in the female rat.
    Ash SL; Goldin BR
    Am J Clin Nutr; 1988 Apr; 47(4):694-9. PubMed ID: 3258469
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.
    Mak RH
    Kidney Int; 1992 Apr; 41(4):1049-54. PubMed ID: 1513086
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E; Canaff L; Fox J; Hendy GN
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D.
    Wilson L; Felsenfeld A; Drezner MK; Llach F
    Kidney Int; 1985 Mar; 27(3):565-73. PubMed ID: 3839029
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating vitamin D metabolite concentrations in childhood renal diseases.
    Chesney RW; Hamstra AJ; Mazess RB; Rose P; DeLuca HF
    Kidney Int; 1982 Jan; 21(1):65-9. PubMed ID: 6978962
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Single-dose oral calcitriol and changes of plasma 1,84iPTH in uremic children.
    Klaus G; Schmidt-Gayk H; Roth HJ; Ritz E; Mehls O
    Adv Perit Dial; 1994; 10():261-6. PubMed ID: 7999841
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 metabolism in calcium-deficient rats.
    Matsumoto T; Ikeda K; Yamato H; Morita K; Ezawa I; Fukushima M; Nishii Y; Ogata E
    Biochem J; 1988 Mar; 250(3):671-7. PubMed ID: 2839142
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of purine derivatives on calcitriol metabolism in rats.
    Hsu CH; Patel SR; Young EW; Vanholder R
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F596-601. PubMed ID: 1849367
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D.
    Portale AA; Halloran BP; Morris RC
    J Clin Invest; 1987 Oct; 80(4):1147-54. PubMed ID: 3654974
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phosphorus intake regulates intestinal function and polyamine metabolism in uremia.
    Imanishi Y; Koyama H; Inaba M; Okuno S; Nishizawa Y; Morii H; Otani S
    Kidney Int; 1996 Feb; 49(2):499-505. PubMed ID: 8821836
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancement of 24,25-dihydroxyvitamin D levels in patients treated with continuous ambulatory peritoneal dialysis.
    Shany S; Rapoport J; Zuili I; Yankowitz N; Chaimovitz C
    Nephron; 1986; 42(2):141-5. PubMed ID: 3003603
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of insulin in the stimulation of renal 1,25-dihydroxyvitamin D synthesis by parathyroid hormone in rats.
    Ikeda K; Matsumoto T; Morita K; Yamato H; Takahashi H; Ezawa I; Ogata E
    Endocrinology; 1987 Nov; 121(5):1721-6. PubMed ID: 3311717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.